Table 3:

The difference in estimated phthalate exposure between specific medical equipment-exposed and non-exposed participants.

		ln (molar sum DEHP (ng/ml))			Average adjusted WQS based on NNNS Attention subscale performance
	N(exposed)	Beta	95% CI	P-value	Beta	95% CI	P-value
PIV	35	0.67	0.33,1.01	<0.001*	1.37	0.37, 2.36	0.007*
Invasive respiratory support	81	0.35	0.05, 0.65	0.023*	0.74	−0.14, 1.61	0.101
Noninvasive respiratory support	19	0.84	0.38,1.30	<0.001*	2.06	0.72, 3.40	0.003*
Feeding tube	126	0.28	−0.14, 0.70	0.190	0.85	−0.35, 2.06	0.163
Central line	25	0.56	0.13, 0.94	0.014*	0.74	−0.42, 1.90	0.213
Incubator	101	0.56	0.25, 0.87	<0.001*	1.46	0.56, 2.37	0.002*

^*p<0.05

Models adjusted for the following covariates: gestational age at birth, status as small for gestational age at birth, and infant gender.